Citation: Ln. Harris et al., INDUCTION OF SENSITIVITY TO DOXORUBICIN AND ETOPOSIDE BY TRANSFECTIONOF MCF-7 BREAST-CANCER CELLS WITH HEREGULIN BETA-2, Clinical cancer research, 4(4), 1998, pp. 1005-1012
Citation: Ln. Harris et al., INDUCTION OF SENSITIVITY TO DOXORUBICIN AND ETOPOSIDE BY TRANSFECTIONOF MCF-7 BREAST-CANCER CELLS WITH HEREGULIN BETA-2, Clinical cancer research, 4(4), 1998, pp. 1005-1012
Citation: Fj. Estevalorenzo et al., SERUM ERBB-2 IN DUCTAL CARCINOMA IN-SITU OF THE BREAST - A MARKER OF MICROINVASION, Acta oncologica, 36(6), 1997, pp. 651-652
Citation: Sm. Swain et Ln. Harris, CAN WE INCREASE SURVIVAL IN BREAST-CANCER WITH INNOVATIVE APPLICATIONS OF CONVENTIONAL DRUGS, European journal of cancer, 30A(4), 1994, pp. 423-424